Anabolic androgenic steroid use population size estimation: a first stage study utilising a Delphi exercise

[1]  J. McVeigh,et al.  Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network , 2021, Harm Reduction Journal.

[2]  J. Andreasson,et al.  Challenging Hegemony Through Narrative: Centering Women’s Experiences and Establishing a Sis-Science Culture Through a Women-Only Doping Forum , 2021, Communication & Sport.

[3]  J. Aloi,et al.  Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men , 2020, American journal of men's health.

[4]  A. Bjørnebekk,et al.  Anabolic-androgenic steroid use among women - A qualitative study on experiences of masculinizing, gonadal and sexual effects. , 2020, The International journal on drug policy.

[5]  H. Reed,et al.  The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England , 2020, International Journal of Drug Policy.

[6]  F. McKay,et al.  A focused netnographic study exploring experiences associated with counterfeit and contaminated anabolic-androgenic steroids , 2020, Harm Reduction Journal.

[7]  E. V. Van Teijlingen,et al.  Support for non-prescribed anabolic androgenic steroids users: a qualitative exploration of their needs , 2020 .

[8]  J. McVeigh,et al.  The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked? , 2020, Drugs: Education, Prevention and Policy.

[9]  L. Westlye,et al.  Structural brain characteristics of anabolic–androgenic steroid dependence in men , 2019, Addiction.

[10]  R. Ralphs,et al.  Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy. , 2019, The International journal on drug policy.

[11]  M. Arieli,et al.  Label misrepresentation in seized anabolic steroids and performance-enhancing substances , 2018, European Journal of Public Health.

[12]  J. McVeigh,et al.  Identifying a typology of men who use anabolic androgenic steroids (AAS). , 2018, The International journal on drug policy.

[13]  R. Guy,et al.  Estimating the number of people who inject drugs in Australia , 2017, BMC Public Health.

[14]  J. McVeigh,et al.  Anabolic steroids in the UK: an increasing issue for public health , 2017 .

[15]  J. Mond,et al.  The Stigma of Anabolic Steroid Use , 2016 .

[16]  K. Sabin,et al.  Availability and Quality of Size Estimations of Female Sex Workers, Men Who Have Sex with Men, People Who Inject Drugs and Transgender Women in Low- and Middle-Income Countries , 2016, PLoS ONE.

[17]  J. McVeigh,et al.  Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study , 2014, Harm Reduction Journal.

[18]  H. Pope,et al.  The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. , 2014, The American journal on addictions.

[19]  R. Wood,et al.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. , 2014, Endocrine reviews.

[20]  C. S. Andreassen,et al.  The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. , 2014, Annals of epidemiology.

[21]  J. Parry,et al.  Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study , 2013, BMJ Open.

[22]  J. McVeigh,et al.  Human enhancement drugs and the pursuit of perfection. , 2012, Adicciones.

[23]  J. McVeigh,et al.  Injecting human growth hormone as a performance-enhancing drug—perspectives from the United Kingdom , 2009 .

[24]  J. Macdougall,et al.  Capture—recapture and anchored prevalence estimation of injecting drug users in England: national and regional estimates , 2009, Statistical methods in medical research.

[25]  Andreas Kimergård,et al.  Elephant in the room? The methodological implications for public health research of performance-enhancing drugs derived from the illicit market. , 2009, Drug testing and analysis.

[26]  T. Rhodes,et al.  Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia. , 2006, Drug and alcohol review.

[27]  D. Hunter,et al.  Qualitative Research: Consensus methods for medical and health services research , 1995 .